A Study of AK138D1 in Advanced Malignant Tumors
NCT07281326
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Cancer
Interventions
DRUG:
AK138D1
Sponsor
Akeso